Morgan Stanley analyst James Faucette downgrades Open Lending (NASDAQ:LPRO) from Equal-Weight to Underweight and lowers the price target from $14 to $8.
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Over the past 3 months, 5 analysts have published their opinion on Open Lending (NASDAQ:LPRO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.